Renin-stimulated TGFβ1 expression is regulated by mitogen-activated protein kinases in mesangial cells (Kidney International (2007) 72, (45-52) DOI: 10.1038/sj.ki.5002243);Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells

Kidney International

Volumn 72, Issue 1, 2007, Pages 45-52

  Huang, Y ^a   Noble, N A ^a,b   Zhang, J ^a   Xu, C ^a   Border, W A ^a  

^a UNIVERSITY OF UTAH   (United States)

^b Fibrosis Research Laboratory   (United States)

Author keywords

Angiotensin II; Mesangial cell; Renin; Signaling

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTOR; RECOMBINANT PROTEIN; RENIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHRONOBIOLOGY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; KIDNEY FIBROSIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; RNA INTERFERENCE;

EID: 34347350179     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.155     Document Type: Erratum

References (36)

1. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828.
2. Nguyen G, Delarue F, Berrou J et al. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 1996; 50: 1897-1903.
3. Nguyen G, Delarue F, Burckle C et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109: 1417-1427.
4. Huang Y, Wongamorntham S, Kasting J et al. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 2006; 69: 105-113.
5. Ohren JF, Chen H, Pavlovsky A et al. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat Struct Mol Biol 2004; 11: 1192-1197.
6. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995; 270: 14843-14846.
7. Vidotti DB, Casarini DE, Cristovam PC et al. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 2004; 286: F1039-F1045.
8. Andrade AQ, Casarini DE, Schor N, Boim MA. Characterization of renin mRNA expression and enzyme activity in rat and mouse mesangial cells. Braz J Med Biol Res 2002; 35: 17-24.
9. Schmitz C, Gotthardt M, Hinderlich S et al. Normal blood pressure and plasma renin activity in mice lacking the renin-binding protein, a cellular renin inhibitor. J Biol Chem 2000; 275: 15357-15362.
10. Saris JJ, Derkx FH, De Bruin RJ et al. High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol Heart Circ Physiol 2001; 280: H1706-H1715.
11. Sealey JE, Catanzaro DF, Lavin TN et al. Specific prorenin/renin binding (ProBP)-identification and characterization of a novel membrane site. Am J Hypertens 1996; 9: 491-502.
12. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998; 74: 49-139.
13. Saris JJ, t Hoen PA, Garrelds IM et al. Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension 2006; 48: 564-571.
14. Burridge K, Wennerberg K. Rho and Rac take center stage. Cell 2004; 116: 167-179.
15. Veniant M, Menard J, Bruneval P et al. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 1996; 98: 1966-1970.
16. Jan Danser AH, Saris JJ. Prorenin uptake in the heart: a prerequisite for local angiotensin generation? J Mol Cell Cardiol 2002; 34: 1463-1472.
17. Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998; 31: 181-188.
18. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. New Engl J Med 1994; 331: 1286-1292.
19. Noble NA, Border WA. Angiotensin II in renal fibrosis: should TGF-b rather than blood pressure be the therapeutic target? Semin Nephrol 1997; 17: 455-466.
20. Manchanda N, Schwartz BS. Single chain urokinase. J Biol Chem 1991; 266: 14580-14584.
21. Huang Y, Noble N. An unexpected role of plasminogen activator inhibitor-type 1 (PAI-1) in renal fibrosis. Kidney Int 2005; 67: 2502-2503.
22. Guo B, Inoki K, Isono M et al. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells. Kidney Int 2005; 68: 972-984.
23. Kutz SM, Hordines J, McKeown-Longo PJ, Higgins PJ. TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. J Cell Sci 2001; 114: 3905-3914.
24. Kaneshiro Y, Ichihara A, Takemitsu T et al. Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int 2006; 70: 641-646.
25. Burckle CA, Jan Danser AH, Muller DN et al. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 2006; 47: 552-556.
26. Gorin Y, Ricono JM, Wagner B et al. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J 2004; 381: 231-239.
27. Naito T, Masaki T, Nikolic-Paterson DJ et al. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol 2004; 286: F278-F287.
28. Perlman A, Lawsin LM, Kolachana P et al. Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase. Ann Clin Lab Sci 2004; 34: 277-286.
29. Terada Y, Kobayashi T, Kuwana H et al. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A. J Am Soc Nephrol 2005; 16: 2296-2305.
30. Nishiyama A, Yao L, Fan Y et al. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 2005; 45: 710-716.
31. Nagai Y, Miyata K, Sun GP et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 2005; 46: 1039-1045.
32. Nishiyama A, Abe Y. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade. J Pharmacol Sci 2006; 100: 9-16.
33. Min LJ, Mogi M, Li JM et al. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Circ Res 2005; 97: 434-442.
34. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 1990; 86: 453-462.
35. Border WA, Okuda S, Languino LR, Ruoslahti E. Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int 1990; 37: 689-695.
36. Huang Y, Haraguchi M, Lawrence DA et al. A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. J Clin Invest 2003; 112: 379-388.